Cricketer Shreyas Iyer Unveils SoBo Mumbai Falcons Yoddhas Jersey and Flags Off 13 Player Contracts to Empower Emerging Talent
Cricketer Shreyas Iyer unveils the SoBo Mumbai Falcons Yoddhas jersey with team owners Ameet H Gadhoke & Pratik Thakur, joined by Kshitij Thakur, Hitendra Thakur & dignitaries
While the Mumbai Falcons have already made headlines by reaching the T20 Mumbai League finals, they are now expanding their legacy beyond the boundary ropes.
Iyer, who recently led his team to the IPL final, presented the first player contract to members of the Mumbai Falcons' Club and Corporate team, as part of a first-of-its-kind official contract ceremony – a significant step toward professionalizing homegrown formats and recognizing untapped potential.
'I'm proud to be associated with the Mumbai Falcons. This isn't just about sport – it's about identity, teamwork, and creating pathways for those who give their all,' said Shreyas Iyer.
'Some of our richest traditions demand as much discipline and skill as mainstream sports, and it's time they get their due.'
The launch included a limited reference to the upcoming indigenous league season, where the yoddhas will complete under their new colours. However the days larger highlight was the announcement of 13 official player contracts, set to be rolled out tomorrow – selected purely on merit and performance, cutting across team boundaries to support emerging athletes across the board.
Mumbai Falcons' Vision: Building the Future of Indian Sport
SoBo Mumbai Falcons are not just building a team they're shaping a movement.
Beyond T20: A Continued Legacy
The Mumbai Falcons are redefining regional franchise models by investing in long-term athlete development, infrastructure, and high-performance environments.
Contracts with Purpose
The upcoming 13 contracts will offer unprecedented growth opportunities, extending to deserving individuals across different sporting disciplines – all based on pure merit.
Professionalism at its Core
By introducing structured contracts, Mumbai Falcons are infusing BCCI-level professionalism into newer formats, and offering world-class infrastructure and career support that rivals international systems.
Setting a National Benchmark
With this approach, SoBo Mumbai Falcons are becoming a blueprint for regional sporting success from cricket to culturally rooted formats offering genuine growth paths for athletes.
Mumbai Falcons Yoddhas Co-owner, Pratik Thakur said, 'Whether it's Racing, cricket or cultural formats, our aim is simple to build systems that recognise skill, promote discipline, and reward perseverance. Our youth need belief, support, and structure. Mumbai Falcons are here to provide all three.'
The Mumbai Falcons' evolving role in India's sporting story goes beyond seasonal wins it reflects a long-term investment in the spirit of competition, community, and culture, extending all the way to the global stage through their international racing team competing in world motorsport championships.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
Britannia Q1 profit misses estimates, sees early signs of urban recovery
Britannia Industries posted first-quarter profit below estimates on Tuesday, but the Indian biscuit maker said urban consumption - dull for a few quarters - is picking up. The seller of 'Marie Gold' and 'Bourbon' biscuits joins other domestic consumer goods makers such as Hindustan Unilever and ITC in forecasting early signs of a recovery in urban demand, aided by easing local inflation. India's annual retail inflation slowed every month in the quarter, easing to a six-year low in June at 2.1 per cent. That helped spur a "marginal uptick in consumption across both urban and rural markets," said Varun Berry, managing director and chief executive. Britannia's quarterly sales grew 9.8 per cent to ₹4,535 crore ($516.5 million). The firm had previously flagged rise in popular demand for packaged food and confectionery items such as croissants, wafers and flavoured shakes - usually more likely to be bought on impulse. But total spends rose 10.4 per cent, led by a 15 per cent jump in raw material costs. Britannia has been hiking prices to partly offset the higher costs of raw materials such as cocoa, flour and palm oil. Profits in the reported quarter came in at ₹521 crore, up 3 per cent on-year, but below analysts' average estimate of ₹570 crore rupees, according to data compiled by LSEG.
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26
Ahmedabad-based Eris Lifesciences is looking to tap opportunities in the nearly Rs 5,000-crore Indian insulin market after Danish drugmaker Novo Nordisk announced the withdrawal of its insulin products from the market in April this year. 'We expect that Novo's cartridge inventory in the market will run out by October 2025. So this market opportunity is something that one can start monetising from the November–December time frame,' the company's executive director and chief executive officer (CEO), Krishnakumar Vaidyanathan, told Business Standard. He added that the timing fits Eris' plans, as the cartridge filling capability of its Bhopal unit will start becoming operational from January. Vial manufacturing has already been commissioned at the unit, with the company creating a strategic stock of insulins. This comes at a time when Eris is already the largest domestic player in insulins. The company had acquired the India formulations business of Biocon Biologics last year — including established insulin brands Basalog and Insugen. 'Before the Biocon deal, we had a couple of homegrown insulin brands in the market, which did a combined Rs 60 crore in revenue last year. Basalog and Insugen had combined revenues of Rs 200 crore at the time of acquisition,' he said. He added that, with this, the company's insulin franchise has become significantly larger, with a 10 per cent market share. Eris is also among the prominent drugmakers looking to roll out generic versions of the blockbuster molecule semaglutide once its patent expires around March next year. Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist used as an active pharmaceutical ingredient in medications for obesity management and Type-II diabetes. According to Eris' investor presentation for the June quarter of 2025–26 (Q1FY26), the company is on track to be among the first launches in India in March 2026. The company has initiated validation of synthetic semaglutide cartridges at its European Union (EU)-approved AMD injectables site. 'We are also planning the validation of the recombinant semaglutide in our Bhopal plant later this year,' he added. As far as the go-to-market strategy is concerned, the company said it is already in a strong position because of its dominant presence in insulins and prior presence in the GLP market with the launch of liraglutide in September last year. For Q1FY26, Eris Lifesciences recorded a 40 per cent year-on-year (Y-o-Y) rise in consolidated profit after tax (PAT) to Rs 125 crore. Revenue rose to Rs 773 crore during the June quarter against Rs 720 crore in the year-ago period.
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
P B Balaji, a CFO who plays with a straight bat, now captains JLR
Balaji's rise to the top spot at JLR as its CEO comes at a time when the company is in a transition phase, lining up plans for more electric vehicles Shine Jacob Chennai Listen to This Article His career moves across the world — from countries like Switzerland and Singapore to cities like London — meant his daughter had to switch nine schools in just 15 years. This is just one glimpse into the lesser-known personal side of the otherwise career-oriented Pathamadai Balachandran Balaji, who was elevated as the first Indian chief executive officer of Tata Motors-owned luxury carmaker Jaguar Land Rover (JLR) on Monday. However, his life is about more than just boardroom talks and business growth. Balaji, in his mid-50s, is a die-hard cricket enthusiast and an admirer of Virat Kohli, yet chooses not to
